![]() |
![]() | ![]() |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
I have long liked this subsidiary of Genzyme and lately it has been under fire for its knee cartillage repair process. The stock is down from 28 3/4 to under 10. I believe it is time for those with more nerve than brains -G- to jump in and buy the shares in the single digits. Not only is the knee product in decent, if controversial shape, but the real boom will be in products still in development. Also, with Genzyme behind genzl, they do not have to worry excessively about burn rate. Any comments will be appreciated and hopefully we will start a profitable adventure on this one. Good luck, Mike Burke | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |